Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists |
Mechanism CRTH2 antagonists(Prostaglandin D2 receptor 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H21FN2O3 |
InChIKeyIJTCACUKYBFEGJ-UHFFFAOYSA-N |
CAS Registry1297280-55-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anaphylaxis | Preclinical | United States | 27 Feb 2014 |